Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Tamil Nadu: Cabinet...

    Tamil Nadu: Cabinet approves land allocation for vaccine plant

    Farhat NasimWritten by Farhat Nasim Published On 2019-02-16T09:15:49+05:30  |  Updated On 16 Feb 2019 9:15 AM IST
    Tamil Nadu: Cabinet approves land allocation for vaccine plant

    The project entails production of viral vaccines such as TCA anti-measles vaccine, Japanese encephalitis and anti-sera at the PII, Coonoor. Land for the project will be transferred free of cost, an official statement said.


    Tamil Nadu: The Union Cabinet on Wednesday approved the allotment of land to Pasteur Institute of India(PII) for setting up of new viral vaccine manufacturing unit at Coonoor in Tamil Nadu.


    Also Read: GSK Pharma to invest Rs 1000 crore in Karnataka plant


    The project entails production of viral vaccines such as TCA anti-measles vaccine, Japanese encephalitis and anti-sera at the PII, Coonoor. Land for the project will be transferred free of cost, an official statement said.


    The allotment of land will encourage the production of life-saving vaccines for children and strengthen the vaccine security of the country. Most of these vaccines are at present imported.

    The Pasteur Institute of India produces DPT vaccine and rabies vaccine for the Expanded Program on Immunization in India.


    The institute was initially called the Pasteur Institute of Southern India. In 1907 it changed its name to the Pasteur Institute of India. In 1977 it became an autonomous body under the Ministry of Health and Family Welfare. The institute is named after the French scientist, Louis Pasteur.


    Also Read: USFDA completes inspection at Caplin Point Lab’s sterile injectable facility in Tamil Nadu

    anti measlesanti seraapprovalcabinetcabinet approvalDPTimmunization programlife saving vaccinePasteur Institute of IndiaPIIPII vaccine plantrabiesTamil NaduTCAUnion Cabinetvaccinevaccine plantviral vaccine
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok